A high intragastric PCO2 (iPCO2), determined tonometrically, is the main factor participating in a low gastric intramucosal pH (pHi) and may point to gastric mucosal ischaemia. iPCO2 might also increase, however, after buffering of gastric acid by bicarbonate; the magnitude of this effect and the efficacy of H2 blockers to prevent it are unclear. Ten healthy volunteers (20-24 years) were studied at baseline and after oral ingestion of 500 mg sodium bicarbonate. The same test was carried out one hour after intravenous injection of 100 mg ranitidine.
Abstract
A high intragastric PCO2 (iPCO2), determined tonometrically, is the main factor participating in a low gastric intramucosal pH (pHi) and may point to gastric mucosal ischaemia. iPCO2 might also increase, however, after buffering of gastric acid by bicarbonate; the magnitude of this effect and the efficacy of H2 blockers to prevent it are unclear. Ten healthy volunteers (20-24 years) were studied at baseline and after oral ingestion of 500 mg sodium bicarbonate. The same test was carried out one hour after intravenous injection of 100 mg ranitidine. A glass pH electrode for continuous gastric juice pH measurements and a Tonomitor catheter were placed 10 cm distally from the gastro-oesophageal junction. iPCO2 was measured in saline boluses, infused at 30 minute intervals in the balloon at the tip of the Tonomitor. Before ranitidine was given, basal iPCO2 (mean (SD)) was (2.53 ) kPa, and increased to [19] [20] (5.87) kPa after sodium bicarbonate (p<0 001). After ranitidine, the gastric juice pH increased from 1-8 (0.9) to 5 6 (1-3) (p<0.05), while basal iPCO2 was 5 60 (0.67) kPa (p<0.01) and did not change after sodium bicarbonate (6-27 (2.27 kPa)). iPCO2 values after acid secretion suppression were similar to those in capillary blood (5.60 (0.40 kPa) The relation, however, between a high iPCO2 and mucosal ischaemia in the stomach might be invalidated if carbon dioxide is produced intraluminally after buffering of gastric acid by salivary, duodenal or gastric bicarbonate.'0 Hence, suppression of acid secretion by H2 receptor blockers has been advocated for proper measurement of iPCO2 and pHi.'0 The magnitude, however, of the buffering effect on iPCO2 and the efficacy of H2 blockers to prevent it are unclear. This uncertainty and the fear that H2 blockade in critically ill patients increases the risk for nosocomial infection"l 12 probably explains why in some studies gastric tonometry was performed in the absence of acid secretion inhibition.5 7 13 An unpaired study in healthy volunteers suggested that iPCO2 is lower after administration of the H2 blocker ranitidine compared with that in untreated subjects. '4 The mechanisms causing this difference remained unclear, because measurement of gastric juice pH, necessary to detect alkaline duodenogastric reflux or salivary bicarbonate entering the stomach, was not performed.
We therefore studied 10 healthy volunteers and measured gastric juice pH and iPCO2 before and after ranitidine, and before and after oral ingestion of a physiological dose of sodium bicarbonate, to simulate buffering of alkali entering the stomach from duodenum or saliva. For calculation of pHi the bicarbonate content in blood taken at t=20 for period I, at t=80 for periods II, III, and IV, and t=230 for periods V, VI, and VII was used. We chose not to draw blood samples for all study periods because it can be calculated that the maximal rise in blood bicarbonate after oral ingestion of 500 mg of sodium bicarbonate, approximately 0-2 mmolIl, would not exceed the error of its measurement.
Patients and methods
We calculated mean, maximum, and minimum pH for every 30 minute period, time matched with measurement of iPCO2. We calculated duration and magnitude of alkaline shifts, defined as a gastric juice pH profile >4 0, during period I and II.19 20 For graphic presentation, we calculated the mean (SD) pH for 90 second periods.
STATISTICAL ANALYSIS
The analysis of variance was used to test for period differences. Thereafter, differences between periods were examined with the paired Student's t test. To examine relations, linear regression analysis was used. A p<0 05 was considered statistically significant. Data were expressed as mean (SD).
Results

GASTRIC JUICE pH
The gastric juice pH (Fig 1) differed between periods (p<0 001). Between period I and II, however, no difference in mean gastric juice pH (1-8 (0 7), and 1 8 (0 9), respectively, p>0 05), in maximum pH (2-97 (1 0) and (1-5), p>0 05), or in time of pH>4-0 (0-3 Vil (0-9) and 1 2 (2-7) minutes, respectively) was found. Ingestion of sodium bicarbonate increased gastric juice pH to 3 5 (2 4) in period uting II); the minimum pH was <4-0 in 4 of 10 volunteers. After ingestion of sodium bicarbonate, the gastric juice pH in period VI increased to 7-1 (0 7) (p<0 005 v period V); in all volunteers the minimum pH was >4 0. In period VII the gastric juice pH was 6-7 (0 7) (p<005 compared with period VI, p<0-01 compared with period V); in 2 of 10 volunteers the minimum pH decreased below 4 0. iPCO2 iPCO2 differed (p<0001) between periods (Fig 2) . Before ranitidine, during period II, basal iPCO2 was 8-40 (2 53) and rose to 19-20 (5 87) kPa in period III after oral sodium bicarbonate (p<0001). This increase in iPCO2 was shortlived, with a iPCO2 of 10-00 (1-71) kPa in period IV (p<OOOI compared with period III, p<O005 compared with period II). After inhibition of acid secretion, basal iPCO2 in period V was 5-60 (0 67) kPa (p<0005 compared with II), and 6&00 (2 27) kPa in period VI during ingestion of sodium bicarbonate (p.005 v V). In this period, the two volunteers with the lowest gastric juice pH immediately before sodium bicarbonate was given, 3-6 and 4-6, showed the highest iPCO2 of 3-87 and 4-53 kPa, respectively. After the sodium bicarbonate, in period VII, iPCO2 was 6-55 (0 85) kPa (p>005 compared with period V).
BLOOD
Blood pH, PCO2, and bicarbonate content did not change during the study period (Table) . Before ranitidine was given, a significant Capillary blood gas analysis in 10 healthy volunteers (mean (SD)) t=230 (period V) 7 -40 (0-02) 42-9 (3 7) 67-7 (8 8) (1-0) difference between intragastric and blood PCO2 was found (Fig 3) , under basal circumstances (period II) of 2-81 (2 28) kPa (p<001), rising to 13-49 (5 75) kPa after sodium bicarbonate ingestion in period III (p<0-001). After ranitidine, the basal iPCO2 in period V and the iPCO2 during sodium bicarbonate ingestion in period VI were similar to blood PCO2 (differing by 0 07 (0-81) and 0A45 (2 77) kPa, respectively, p>005). In period VII, during which gastric acid secretion recurred in some subjects, a small, but significant difference between intragastric and blood PCO2 (0-83 (0 95) kPa, p<005) was again noticed, however. pHi Before ranitidine, basal pHi was 7-24 (0-13) decreasing to 6-89 (0-15) during sodium bicarbonate ingestion in period III (p<0-00 1). After ranitidine was given in period V, basal pHi was 7-41 (0.06), higher than pHi before acid secretion suppression in period II (p<0 005), and 7-39 (0-21) during sodium bicarbonate ingestion in period VI (p.0 05 compared with period V). As blood bicarbonate content was constant during the study, calculated pHi inversely followed changes in iPCO2 (Fig 4) Figure 3 : Difference between iPCO2 and capillary blood PCO2 ( mean (SD) (n= 10). Period I, II, and V basal values, period II ingestion of 500 mg sodium bicarbonate, and period IV and VII ingestion of oral sodium bicarbonate. Periods I-IV before 100 mg intravenously, period V-VII after ranitidine was given TB: oral sodium bicarbonate, TR: 100 mg ranitidine given intravenously.
Study periods
of these hydrogen ions production of CO2. As across the gastrointestinal intraluminal PCO2 will r Our study confirms anc by Heard et al,14 suggestir acid secretion decreases that study there were comparisons. As suppresE does not affect basal gar fall in iPCO2 with H2 explained by less bufferinj or salivary bicarbonate e This is unlikely, howeve gastric juice pH data sh between alkaline shifts an the most probable cause during normal v suppr( is either buffering of ga ise during ischaemia. of CO2 from mucosa to lumen.39 Thus, when i extends the findings performing gastric tonometry, CO2 diffuses ig that suppression of comparatively rapidly from the surrounding basal iPCO2, but in mucosa to the saline in the gastric balloon. no within subject Conversely, the high intragastric PCO2 after sion of acid secretion exogenous sodium bicarbonate, presumably stric blood flow, the did not lead to severe gastric intramucosal blockade might be acidosis because the period of increased PCO2 g of acid by duodenal is too short for complete diffusion of produced ntering the stomach. CO2 into the mucosa. Hence, the calculated r, as analysis of the pHi of 6-89 (0 15) overestimates true gastric lowed no correlation mucosal acidity. The calculated pHi of [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] id iPCO2. Therefore, (0 13), however, during steady state CO2 of a higher iPCO2 generation in the presence of acid secretion essed acid secretion (period II), compared with the pHi after tstric acid by gastric ranitidine (7- In conclusion, our results in healthy volunteers show that the proper determination of iPCO2 as a measure of gastric mucosal PCO2 and thus the adequacy of gastric mucosal blood flow, necessitates suppression of acid secretion. After ranitidine, iPCO2 equals the PCO2 in capillary blood. The gradient between iPCO2 and blood PCO2 during acid secretion is probably caused by buffering of gastric acid by gastric mucosal or duodenal bicarbonate.
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